Clorox (NYSE:CLX – Get Free Report) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 6.650-6.900 for the period, compared to the consensus earnings per share estimate of 6.650. The company issued revenue guidance of $7.0 billion-$7.1 billion, compared to the consensus revenue estimate of $7.0 billion. Clorox also updated its FY25 guidance to $6.65-$6.90 EPS.
Wall Street Analyst Weigh In
A number of research firms have recently commented on CLX. BNP Paribas raised shares of Clorox to a “strong sell” rating in a research note on Friday, September 6th. TD Cowen started coverage on Clorox in a research report on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price objective for the company. Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and raised their target price for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. JPMorgan Chase & Co. raised their price objective on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. Finally, Barclays boosted their target price on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research report on Friday. Six analysts have rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $150.29.
Clorox Stock Performance
Clorox (NYSE:CLX – Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 292.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the business posted $0.49 earnings per share. The business’s quarterly revenue was up 27.0% on a year-over-year basis. On average, analysts forecast that Clorox will post 6.64 earnings per share for the current fiscal year.
Clorox Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be issued a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.99%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s payout ratio is currently 170.04%.
Insider Buying and Selling
In related news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.57% of the stock is owned by corporate insiders.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
- Five stocks we like better than Clorox
- What is Short Interest? How to Use It
- Battle of the Retailers: Who Comes Out on Top?
- How to Calculate Return on Investment (ROI)
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- Comparing and Trading High PE Ratio Stocks
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.